{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T22:07:04Z","timestamp":1787263624631,"version":"build-2736575974"},"reference-count":71,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Atopic dermatitis (AD) presents a multidimensional burden, often beginning in infancy and accumulating over time. Beyond itch and pain, AD is associated with significant losses of health-related quality of life resulting from sleep disturbance, stigmatization, other atopic diseases and nonatopic comorbidities, among others. These associated conditions affect patients' physical and mental health, development, social interaction and productivity, resulting in what has been termed cumulative life course impairment (CLCI). To alter the trajectory of AD and improve patient outcomes, it is important to identify people at risk of CLCI, measure it in clinical practice and intervene with appropriate treatment. Although a digital, structured questionnaire for adults exists, a separate instrument to assess CLCI in children and adolescents would benefit our understanding of these issues in a patient population in need. This paper discusses the need for such a questionnaire, with the goal of increasing awareness of the lifelong impact of AD among healthcare professionals, caregivers and patients, potentially improving shared decision-making and facilitating conversations about treatment.<\/jats:p>","DOI":"10.2340\/actadv.v106.adv-2025-0066","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:22:31Z","timestamp":1781670151000},"source":"Crossref","is-referenced-by-count":1,"title":["Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course Impairment"],"prefix":"10.2340","volume":"106","author":[{"given":"Matthias","family":"Augustin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Amerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Bewley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Gieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gutermuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa B.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"159181","doi-asserted-by":"crossref","unstructured":"Darnton-Hill I, Nishida C, James WPT. A life course approach to diet, nutrition and the prevention of chronic diseases. Public Health Nutr 2004; 7: 101\u2013121.","DOI":"10.1079\/PHN2003584"},{"key":"159182","doi-asserted-by":"crossref","unstructured":"Hanson HA, Leiser CL, Bandoli G, Pollock BH, Karagas MR, Armstrong D, et al. Charting the life course: emerging opportunities to advance scientific approaches using life course research. J Clin Transl Sci 2020; 5: e9.","DOI":"10.1017\/cts.2020.492"},{"key":"159183","doi-asserted-by":"crossref","unstructured":"Kimball AB, Gieler U, Linder D, Sampogna F, Warren RB, Augustin M. Psoriasis: is the impairment to a patient\u2019s life cumulative? J Eur Acad Dermatol Venereol 2010; 24: 989\u20131004.","DOI":"10.1111\/j.1468-3083.2010.03705.x"},{"key":"159184","unstructured":"Linder MD, Piaserico S, Augustin M, Fortina AB, Cohen AD, Gieler U, et al. Psoriasis - the life course approach. Acta Derm Venereol 2016; 96: 102\u2013108."},{"key":"159185","doi-asserted-by":"crossref","unstructured":"Doroudian Tehrani M, Gibson RS, Snyder CL, Porter ML, Kimball AB. Cumulative life course impairment: evidence for hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2025; 39: 1395\u20131409.","DOI":"10.1111\/jdv.20607"},{"key":"159186","doi-asserted-by":"crossref","unstructured":"von St\u00fclpnagel CC, Augustin M, D\u00fcpmann L, da Silva N, Sommer R. Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases \u2013 a systematic review. J Eur Acad Dermatol Venereol 2021; 35: 2166\u20132184.","DOI":"10.1111\/jdv.17348"},{"key":"159187","doi-asserted-by":"crossref","unstructured":"Missmer SA, Tu FF, Agarwal SK, Chapron C, Soliman AM, Chiuve S, et al. Impact of endometriosis on life-course potential: a narrative review. Int J Gen Med 2021; 14: 9\u201325.","DOI":"10.2147\/IJGM.S261139"},{"key":"159188","doi-asserted-by":"crossref","unstructured":"Silverberg NB, Dur\u00e1n-McKinster C. Special considerations for therapy of pediatric atopic dermatitis. Dermatol Clin 2017; 35: 351\u2013363.","DOI":"10.1016\/j.det.2017.02.008"},{"key":"159189","doi-asserted-by":"crossref","unstructured":"Brenninkmeijer EEA, Legierse CM, Sillevis Smitt JH, Last BF, Grootenhuis MA, Bos JD. The course of life of patients with childhood atopic dermatitis. Pediatr Dermatol 2009; 26: 14\u201322.","DOI":"10.1111\/j.1525-1470.2008.00745.x"},{"key":"159190","doi-asserted-by":"crossref","unstructured":"Arancio LMH, D\u2019Amico D, Dastoli S, Fiorella CS, Manfredini M, Moretta G, et al. Early intervention and cumulative life course impairment in psoriasis: a review. Clin Exp Dermatol 2024; 49: 1525\u20131531.","DOI":"10.1093\/ced\/llae282"},{"key":"159191","doi-asserted-by":"crossref","unstructured":"Felix PAO, Sampaio AL, Silva BL, Viana ALP. Early intervention in psoriasis: Where do we go from here? Front Med 2022; 9: 1027347.","DOI":"10.3389\/fmed.2022.1027347"},{"key":"159192","doi-asserted-by":"crossref","unstructured":"Romiti R, Magalh\u00e3es RF, Duarte GV. Cumulative life course impairment in patients with dermatological diseases, with a focus on psoriasis. An Bras Dermatol 2024; 99: 269\u2013276.","DOI":"10.1016\/j.abd.2023.08.006"},{"key":"159193","doi-asserted-by":"crossref","unstructured":"Fasseeh AN, Elezbawy B, Korra N, Tannira M, Dalle H, Aderian S, et al. Burden of atopic dermatitis in adults and adolescents: a systematic literature review. Dermatol Ther (Heidelb) 2022; 12: 2653\u20132668.","DOI":"10.1007\/s13555-022-00819-6"},{"key":"159194","doi-asserted-by":"crossref","unstructured":"Hon KL, Tsang YCK, Poon TCW, Pong NH, Kwan M, Lau S, et al. Predicting eczema severity beyond childhood. World J Pediatr 2016; 12: 44\u201348.","DOI":"10.1007\/s12519-015-0064-9"},{"key":"159195","doi-asserted-by":"crossref","unstructured":"Achten R, Van der Rijst L, Piena M, Lamers H, De Beer F, De Bruin-Weller M, et al. Economic and humanistic burden in paediatric patients with atopic dermatitis. Acta Derm Venereol 2023; 103: adv00881.","DOI":"10.2340\/actadv.v103.4842"},{"key":"159196","doi-asserted-by":"crossref","unstructured":"Stingeni L, Belloni Fortina A, Baiardini I, Hansel K, Moretti D, Cipriani F. Atopic dermatitis and patient perspectives: insights of bullying at school and career discrimination at work. J Asthma Allergy 2021; 14: 919\u2013928.","DOI":"10.2147\/JAA.S317009"},{"key":"159197","doi-asserted-by":"crossref","unstructured":"Weidinger S, Simpson EL, Silverberg JI, Barbarot S, Eckert L, Mina-Osorio P, et al. Burden of atopic dermatitis in paediatric patients: an international cross-sectional study. Br J Dermatol 2024; 190: 846\u2013857.","DOI":"10.1093\/bjd\/ljad449"},{"key":"159198","doi-asserted-by":"crossref","unstructured":"Augustin M, Misery L, von Kobyletzski L, Mealing S, Redding M, Chuang CC, et al. Systematic literature review assessing the overall costs and societal impacts of moderate\u2010to\u2010severe atopic dermatitis in Europe. J Eur Acad Dermatol Venereol 2022; 36: 2316\u20132324.","DOI":"10.1111\/jdv.18481"},{"key":"159199","doi-asserted-by":"crossref","unstructured":"Chung J, Simpson EL. The socioeconomics of atopic dermatitis. Ann Allergy Asthma Immunol 2019; 122: 360\u2013366.","DOI":"10.1016\/j.anai.2018.12.017"},{"key":"159200","doi-asserted-by":"crossref","unstructured":"Ramirez FD, Chen S, Langan SM, Prather AA, McCulloch CE, Kidd SA, et al. Association of atopic dermatitis with sleep quality in children. JAMA Pediatr 2019; 173: e190025.","DOI":"10.1001\/jamapediatrics.2019.0025"},{"key":"159201","doi-asserted-by":"crossref","unstructured":"Chang YS, Chiang BL. Sleep disorders and atopic dermatitis: A 2-way street? J Allergy Clin Immunol 2018; 142: 1033\u20131040.","DOI":"10.1016\/j.jaci.2018.08.005"},{"key":"159202","doi-asserted-by":"crossref","unstructured":"Cameron S, Donnelly A, Broderick C, Arichi T, Bartsch U, Dazzan P, et al. Mind and skin: exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitis. Allergy 2024; 79: 26\u201336.","DOI":"10.1111\/all.15818"},{"key":"159203","doi-asserted-by":"crossref","unstructured":"Silverberg JI, Paller AS. Association between eczema and stature in 9 US population-based studies. JAMA Dermatol 2015; 151: 401\u2013409.","DOI":"10.1001\/jamadermatol.2014.3432"},{"key":"159204","doi-asserted-by":"crossref","unstructured":"Wu D, Wu XD, Zhou X, Huang W, Luo C, Liu Y. Bone mineral density, osteopenia, osteoporosis, and fracture risk in patients with atopic dermatitis: a systematic review and meta- analysis. Ann Transl Med 2021; 9: 40.","DOI":"10.21037\/atm-20-4708"},{"key":"159205","doi-asserted-by":"crossref","unstructured":"Romanos M, Gerlach M, Warnke A, Schmitt J. Association of attention-deficit\/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 2010; 64: 269\u2013273.","DOI":"10.1136\/jech.2009.093534"},{"key":"159206","doi-asserted-by":"crossref","unstructured":"Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol 2013; 131: 428\u2013433.","DOI":"10.1016\/j.jaci.2012.10.041"},{"key":"159207","doi-asserted-by":"crossref","unstructured":"Schans J van der, \u00c7i\u00e7ek R, de Vries TW, Hak E, Hoekstra PJ. Association of atopic diseases and attention-deficit\/hyperactivity disorder: a systematic review and meta-analyses. Neurosci Biobehav Rev 2017; 74: 139\u2013148.","DOI":"10.1016\/j.neubiorev.2017.01.011"},{"key":"159208","doi-asserted-by":"crossref","unstructured":"Ma EZ, Chang HR, Radtke S, Wan J. Symptoms of cognitive impairment among children with atopic dermatitis. JAMA Dermatol 2024; 160: 447\u2013452.","DOI":"10.1001\/jamadermatol.2024.0015"},{"key":"159209","doi-asserted-by":"crossref","unstructured":"Huang AH, Roh YS, Sutaria N, Choi J, Williams KA, Canner JK, et al. Real-world comorbidities of atopic dermatitis in the pediatric ambulatory population in the United States. J Am Acad Dermatol 2021; 85: 893\u2013900.","DOI":"10.1016\/j.jaad.2021.03.016"},{"key":"159210","doi-asserted-by":"crossref","unstructured":"Thyssen JP, Halling AS, Schmid-Grendelmeier P, Guttman-Yassky E, Silverberg JI. Comorbidities of atopic dermatitis-what does the evidence say? J Allergy Clin Immunol 2023; 151: 1155\u20131162.","DOI":"10.1016\/j.jaci.2022.12.002"},{"key":"159211","unstructured":"Bantz SK, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol 2014; 5: 202."},{"key":"159212","doi-asserted-by":"crossref","unstructured":"Choi UE, Deng J, Parthasarathy V, Liao V, D\u2019Amiano A, Taylor M, et al. Risk factors and temporal associations of progression of the atopic march in children with early-onset atopic dermatitis. J Am Acad Dermatol 2025; 92: 732\u2013740.","DOI":"10.1016\/j.jaad.2024.10.107"},{"key":"159213","doi-asserted-by":"crossref","unstructured":"Silverberg JI, Simpson EL. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr Allergy Immunol 2013; 24: 476\u2013486.","DOI":"10.1111\/pai.12095"},{"key":"159214","doi-asserted-by":"crossref","unstructured":"Dierick BJH, van der Molen T, Flokstra-de Blok BMJ, Muraro A, Postma MJ, Kocks JWH, et al. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Expert Rev Pharmacoecon Outcomes Res 2020; 20: 437\u2013453.","DOI":"10.1080\/14737167.2020.1819793"},{"key":"159215","doi-asserted-by":"crossref","unstructured":"Haanp\u00e4\u00e4 L, Af Ursin P, Nermes M, Kaljonen A, Isolauri E. Association of allergic diseases with children\u2019s life satisfaction: population-based study in Finland. BMJ Open 2018; 8: e019281.","DOI":"10.1136\/bmjopen-2017-019281"},{"key":"159216","doi-asserted-by":"crossref","unstructured":"Valero-Moreno S, Torres-Llanos R, P\u00e9rez-Mar\u00edn M. Impact of childhood food allergy on quality of life: a systematic review. Appl Sci 2024; 14: 10989.","DOI":"10.3390\/app142310989"},{"key":"159217","doi-asserted-by":"crossref","unstructured":"Nanda MK, LeMasters GK, Levin L, Rothenberg ME, Assa\u2019ad AH, Newman N, et al. Allergic diseases and internalizing behaviors in early childhood. Pediatrics 2016; 137: e20151922.","DOI":"10.1542\/peds.2015-1922"},{"key":"159218","doi-asserted-by":"crossref","unstructured":"R\u00f8nnstad ATM, Halling-Overgaard AS, Hamann CR, Skov L, Egeberg A, Thyssen JP. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis. J Am Acad Dermatol 2018; 79: 448\u2013456.","DOI":"10.1016\/j.jaad.2018.03.017"},{"key":"159219","doi-asserted-by":"crossref","unstructured":"Kern C, Wan J, LeWinn KZ, Ramirez FD, Lee Y, McCulloch CE, et al. Association of atopic dermatitis and mental health outcomes across childhood: a longitudinal cohort study. JAMA Dermatol 2021; 157: 1200\u20131208.","DOI":"10.1001\/jamadermatol.2021.2657"},{"key":"159220","doi-asserted-by":"crossref","unstructured":"Johnson JK, Loiselle A, Chatrath S, Smith Begolka W. Patient and caregiver perspectives on the relationship between atopic dermatitis symptoms and mental health. Dermatitis 2024; 35: 386\u2013391.","DOI":"10.1089\/derm.2023.0365"},{"key":"159221","doi-asserted-by":"crossref","unstructured":"Hou A, Silverberg JI. Predictors and age-dependent pattern of psychologic problems in childhood atopic dermatitis. Pediatr Dermatol 2021; 38: 606\u2013612.","DOI":"10.1111\/pde.14588"},{"key":"159222","doi-asserted-by":"crossref","unstructured":"Neri I, Galli E, Baiardini I, Picozza M, Rossi AB, Matruglio P, et al. Implications of atopic dermatitis on the quality of life of 6\u201311-year-old children and caregivers (PEDI-BURDEN). J Asthma Allergy 2023; 16: 383\u2013396.","DOI":"10.2147\/JAA.S404350"},{"key":"159223","doi-asserted-by":"crossref","unstructured":"Hua T, Silverberg JI. Atopic dermatitis in US adults: epidemiology, association with marital status, and atopy. Ann Allergy Asthma Immunol 2018; 121: 622\u2013624.","DOI":"10.1016\/j.anai.2018.07.019"},{"key":"159224","doi-asserted-by":"crossref","unstructured":"von Kobyletzki L, Henrohn D, Ballardini N, Neary MP, Orts\u00e4ter G, Rieem Dun A, et al. Comorbidities in childhood atopic dermatitis: a population\u2010based study. J Eur Acad Dermatol Venereol 2024; 38: 354\u2013364.","DOI":"10.1111\/jdv.19569"},{"key":"159225","doi-asserted-by":"crossref","unstructured":"Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol 2021; 126: 3\u201312.","DOI":"10.1016\/j.anai.2020.08.002"},{"key":"159226","doi-asserted-by":"crossref","unstructured":"Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol 2015; 135: 56\u201366.","DOI":"10.1038\/jid.2014.325"},{"key":"159227","doi-asserted-by":"crossref","unstructured":"Girolomoni G, Luger T, Nosbaum A, Gruben D, Romero W, Llamado LJ, et al. The economic and psychosocial comorbidity burden among adults with moderate-to-severe atopic dermatitis in Europe: analysis of a cross-sectional survey. Dermatol Ther 2021; 11: 117\u2013130.","DOI":"10.1007\/s13555-020-00459-8"},{"key":"159228","doi-asserted-by":"crossref","unstructured":"Mohr N, Augustin M, Zeervi L, Bieber T, Werfel T, Wollenberg A, et al. Determinants of costs and benefits in atopic dermatitis routine care in Germany. J Eur Acad Dermatol Venereol 2022; 36: 1450\u20131455.","DOI":"10.1111\/jdv.18169"},{"key":"159229","doi-asserted-by":"crossref","unstructured":"Wan J, Fuxench ZCC, Wang S, Syed MN, Shin DB, Abuabara K, et al. Incidence of cardiovascular disease and venous thromboembolism in patients with atopic dermatitis. J Allergy Clin Immunol Pract 2023; 11: 3123\u20133132.","DOI":"10.1016\/j.jaip.2023.08.007"},{"key":"159230","doi-asserted-by":"crossref","unstructured":"Lee SW, Kim H, Byun Y, Baek YS, Choi CU, Kim JH, et al. Incidence of cardiovascular disease after atopic dermatitis development: a nationwide, population-based study. Allergy Asthma Immunol Res 2023; 15: 231\u2013245.","DOI":"10.4168\/aair.2023.15.2.231"},{"key":"159231","doi-asserted-by":"crossref","unstructured":"Augustin M, Radtke MA, Glaeske G, Reich K, Christophers E, Schaefer I, et al. Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatology 2015; 231: 35\u201340.","DOI":"10.1159\/000381913"},{"key":"159232","doi-asserted-by":"crossref","unstructured":"Ascott A, Mansfield KE, Schonmann Y, Mulick A, Abuabara K, Roberts A, et al. Atopic eczema and obesity: a population-based study. Br J Dermatol 2021; 184: 871\u2013879.","DOI":"10.1111\/bjd.19597"},{"key":"159233","doi-asserted-by":"crossref","unstructured":"Augustin M, Langenbruch A, Blome C, Gutknecht M, Werfel T, St\u00e4nder S, et al. Characterizing treatment\u2010related patient needs in atopic eczema: insights for personalized goal orientation. Acad Dermatol Venereol 2020; 34: 142\u2013152.","DOI":"10.1111\/jdv.15919"},{"key":"159234","doi-asserted-by":"crossref","unstructured":"Irvine AD, Mina-Osorio P. Disease trajectories in childhood atopic dermatitis: an update and practitioner\u2019s guide. Br J Dermatol 2019; 181: 895\u2013906.","DOI":"10.1111\/bjd.17766"},{"key":"159235","doi-asserted-by":"crossref","unstructured":"Jacobson ME, Seshadri RS, Morimoto R, Grinich E, Haag C, Nguyen K, et al. Early intervention and disease modification in atopic dermatitis-the current state of the field and barriers to progress. J Eur Acad Dermatol Venereol 2024; 38: 665\u2013672.","DOI":"10.1111\/jdv.19699"},{"key":"159236","doi-asserted-by":"crossref","unstructured":"Ranzinger D, Eyerich K. Disease modification in psoriasis: future prospects for long-term remission. Am J Clin Dermatol 2025; 26: 477\u2013486.","DOI":"10.1007\/s40257-025-00949-5"},{"key":"159237","doi-asserted-by":"crossref","unstructured":"Bieber T. Disease modification in inflammatory skin disorders: opportunities and challenges. Nat Rev Drug Discov 2023; 22: 662\u2013680.","DOI":"10.1038\/s41573-023-00735-0"},{"key":"159238","doi-asserted-by":"crossref","unstructured":"Bacci ED, Correll JR, Pierce EJ, Atwater AR, Dawson Z, Begolka WS, et al. Burden of adult atopic dermatitis and unmet needs with existing therapies. J Dermatolog Treat 2023; 34: 2202288.","DOI":"10.1080\/09546634.2023.2202288"},{"key":"159239","doi-asserted-by":"crossref","unstructured":"Paller AS, Guttman-Yassky E, Schuttelaar MLA, Irvine AD, Baselga E, Kataoka Y, et al. Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: interim results from the PEDISTAD Real-World Registry. J Am Acad Dermatol 2022; 87: 1104\u20131108.","DOI":"10.1016\/j.jaad.2022.01.018"},{"key":"159240","doi-asserted-by":"crossref","unstructured":"Eyerich K, Gooderham MJ, Silvestre JF, Shumack SP, Mendes-Bastos P, Aoki V, et al. Real-world clinical, psychosocial and economic burden of atopic dermatitis: results from a multicountry study. J Eur Acad Dermatol Venereol 2024; 38:340\u2013353.","DOI":"10.1111\/jdv.19500"},{"key":"159241","doi-asserted-by":"crossref","unstructured":"Kleyn CE, Barbarot S, Reed C, Losi S, von Arx LB, Robert C, et al. Burden of moderate to severe atopic dermatitis in adults from France, Italy, and the UK: patient-reported outcomes and treatment patterns. Dermatol Ther 2022; 12: 1947\u20131965.","DOI":"10.1007\/s13555-022-00777-z"},{"key":"159242","doi-asserted-by":"crossref","unstructured":"Calzavara-Pinton P, \u010celakovsk\u00e1 J, Lapeere H, Holzer G, Al-Ahmad M, Chu CY, et al. Baseline demographics, comorbidities, treatment patterns and burden of atopic dermatitis in adults and adolescents from the GLOBOSTAD long-term observational study. Adv Ther 2023; 40: 5366\u20135382.","DOI":"10.1007\/s12325-023-02644-5"},{"key":"159243","doi-asserted-by":"crossref","unstructured":"Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: a population-based cohort study. J Am Acad Dermatol 2024; 91: 466\u2013473.","DOI":"10.1016\/j.jaad.2024.05.029"},{"key":"159244","doi-asserted-by":"crossref","unstructured":"Strober B, Mallya UG, Yang M, Ganguli S, Gadkari A, Wang J, et al. Treatment outcomes associated with dupilumab use in patients with atopic dermatitis: 1-year results from the RELIEVE-AD study. JAMA Dermatol 2022; 158: 142\u2013150","DOI":"10.1001\/jamadermatol.2021.4778"},{"key":"159245","doi-asserted-by":"crossref","unstructured":"Braren-von St\u00fclpnagel CC, Augustin M, Westphal L, Sommer R. Development of measurement tools to assess cumulative life course impairment in patients with chronic skin diseases. J Eur Acad Dermatol Venereol 2023; 37: 1626\u20131633.","DOI":"10.1111\/jdv.18977"},{"key":"159246","doi-asserted-by":"crossref","unstructured":"Ho MJ, Sultana R, Choo K, Lee HY. Cumulative life course impairment in moderate-to-severe atopic dermatitis: a cross-sectional study in Singapore. Dermatology 2025; 241: 425\u2013436.","DOI":"10.1159\/000548368"},{"key":"159247","doi-asserted-by":"crossref","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210\u2013216.","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"159248","doi-asserted-by":"crossref","unstructured":"Hanifin JM, Baghoomian W, Grinich E, Leshem YA, Jacobson M, Simpson EL. The Eczema Area and Severity Index\u2014a practical guide. Dermatitis 2022; 33: 187\u2013192.","DOI":"10.1097\/DER.0000000000000895"},{"key":"159249","doi-asserted-by":"crossref","unstructured":"Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients\u2019 perspective. Arch Dermatol 2004; 140: 1513\u20131519.","DOI":"10.1001\/archderm.140.12.1513"},{"key":"159250","doi-asserted-by":"crossref","unstructured":"Augustin M. Cumulative life course impairment: identifying patients at risk. Curr Probl Dermatol 2013; 44: 74\u201381.","DOI":"10.1159\/000350555"},{"key":"159251","doi-asserted-by":"crossref","unstructured":"Heratizadeh A, Mempel M, von Kiedrowski R, Hagl S, Mosch T, Fritz B, et al. Checklist identification of candidates for systemic therapy in adult patients with atopic dermatitis in Germany: a multicentre study. J Eur Acad Dermatol Venereol 2024; 38: 157\u2013166.","DOI":"10.1111\/jdv.19465"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46340\/54393","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46340\/54394","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46340\/54395","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46340\/54393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:23:02Z","timestamp":1781670182000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/46340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":71,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2025-0066","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}